newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces First Quarter 2021 Financial and Business Results

● Q1 Revenue of $9.8 Million is Company's Highest as Combined Molecular Diagnostics and Pharma Services Business ● Q2 Revenue Expected to Exceed $11 million ● On Track to Exceed Full Year 2021 Revenue Growth of 35% ●Moving Up Target For E